AbbVie
ABBV
HK$1,565
Share price
-3.74%
Change (1 day)
12.10%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Total debt
Total debt on the balance sheet as of December 2024 : HK$522.03 Billion
According to AbbVie's latest financial reports the company's total debt is HK$522.03 Billion. A company’s total debt is the sum of all current and non-current debts.
AbbVie - Total debt on balance sheet (from 2011 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | HK$521.27 B | 12.39% |
| 2023-12-31 | HK$463.79 B | -6.18% |
| 2022-12-31 | HK$494.35 B | -17.33% |
| 2021-12-31 | HK$597.94 B | -10.37% |
| 2020-12-31 | HK$667.12 B | 28.37% |
| 2019-12-31 | HK$519.68 B | 64.63% |
| 2018-12-31 | HK$315.66 B | 8.12% |
| 2017-12-31 | HK$291.95 B | 2.19% |
| 2016-12-31 | HK$285.69 B | 16.38% |
| 2015-12-31 | HK$245.47 B | 111.31% |
| 2014-12-31 | HK$116.16 B | 1.75% |
| 2013-12-31 | HK$114.16 B | -6.02% |
| 2012-12-31 | HK$121.47 B | 32484% |
| 2011-12-31 | HK$0.37 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | HK$494.85 B | -5.21% | 🇺🇸 USA |
 | HK$398.06 B | -23.75% | 🇺🇸 USA |
 | HK$261.57 B | -49.89% | 🇺🇸 USA |
 | HK$467.25 B | -10.49% | 🇺🇸 USA |
 | HK$207.67 B | -60.22% | 🇺🇸 USA |
 | HK$51.54 B | -90.13% | 🇺🇸 USA |
 | HK$165.72 B | -68.25% | 🇬🇧 UK |
 | HK$234.13 B | -55.15% | 🇬🇧 UK |
 | HK$3.53 B | -99.32% | 🇺🇸 USA |